secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001558370-25-004511
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aerovate announces $67.6-69.6M cash dividend range for proposed merger; stockholder vote April 16
--------------------------------------------------------------------------------

- Cash dividend expected $67.6-69.6M in aggregate, based on estimated net cash prior to merger closing.
- As of April 4, 2025, 28,985,019 shares of common stock outstanding.
- Stockholders vote on merger at special meeting scheduled for April 16, 2025 at 9:00 a.m. ET.
- Closing expected no later than April 30, 2025, subject to stockholder approval and other conditions.
- Dividend expected to be a return of capital, not characterized as dividend for tax purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000155837025004511/0001558370-25-004511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000155837025004511/avte-20250407x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-004511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer